Kerala Ayurveda Share Price
Sector: Healthcare Facilities
436.40 +2.30 (0.53%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
428.05
Today’s High
442
52 Week Low
250
52 Week High
486.90
Key Metrics
- Market Cap (In Cr) 525.09
- Beta 0.35
- Div. Yield (%) 0
- P/B 16.24
- TTM P/E 439.94
- Peg Ratio -
- Sector P/E 24.46
- Open Price 440
- Prev Close 434.1
Kerala Ayurveda Analysis
Price Analysis
-
1 Week10.07%
-
3 Months38.47%
-
6 Month45.82%
-
YTD-1.5%
-
1 Year47.63%
Risk Meter
- 61% Low risk
- 61% Moderate risk
- 61% Balanced Risk
- 61% High risk
- 61% Extreme risk
Kerala Ayurveda News
Porinju Veliyath buys stake in this multibagger stock. Share hits life-time high
2 min read . 05 Oct 2023Kerala Ayurveda Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 107.86
- Selling/ General/ Admin Expenses Total
- 34.27
- Depreciation/ Amortization
- 1.34
- Other Operating Expenses Total
- 43.35
- Total Operating Expense
- 100.92
- Operating Income
- 6.93
- Net Income Before Taxes
- 1.27
- Net Income
- -1.53
- Diluted Normalized EPS
- -1.38
- Period
- 2024
- Total Assets
- 140.71
- Total Liabilities
- 108.54
- Total Equity
- 32.16
- Tangible Book Valueper Share Common Eq
- 8.2
- Period
- 2024
- Cashfrom Operating Activities
- 2.03
- Cashfrom Investing Activities
- -1.26
- Cashfrom Financing Activities
- 17.64
- Net Changein Cash
- 18.42
- Period
- 2023
- Total Revenue
- 93.41
- Selling/ General/ Admin Expenses Total
- 28.12
- Depreciation/ Amortization
- 1.11
- Other Operating Expenses Total
- 39.5
- Total Operating Expense
- 85.94
- Operating Income
- 7.47
- Net Income Before Taxes
- -0.56
- Net Income
- -0.9
- Diluted Normalized EPS
- -2.6
- Period
- 2023
- Total Assets
- 115.9
- Total Liabilities
- 110.32
- Total Equity
- 5.58
- Tangible Book Valueper Share Common Eq
- -15.97
- Period
- 2023
- Cashfrom Operating Activities
- 9.86
- Cashfrom Investing Activities
- -7.22
- Cashfrom Financing Activities
- -1.14
- Net Changein Cash
- 1.5
- Period
- 2022
- Total Revenue
- 80.35
- Selling/ General/ Admin Expenses Total
- 23.84
- Depreciation/ Amortization
- 1.2
- Other Operating Expenses Total
- 29.96
- Total Operating Expense
- 71.38
- Operating Income
- 8.98
- Net Income Before Taxes
- 2.8
- Net Income
- 2.36
- Diluted Normalized EPS
- 1.59
- Period
- 2022
- Total Assets
- 110.32
- Total Liabilities
- 104.21
- Total Equity
- 6.11
- Tangible Book Valueper Share Common Eq
- -15.43
- Period
- 2022
- Cashfrom Operating Activities
- -0.5
- Cashfrom Investing Activities
- -1.91
- Cashfrom Financing Activities
- -13.27
- Net Changein Cash
- -15.69
- Period
- 2021
- Total Revenue
- 62.07
- Selling/ General/ Admin Expenses Total
- 23.32
- Depreciation/ Amortization
- 1.28
- Other Operating Expenses Total
- 23.01
- Total Operating Expense
- 62.6
- Operating Income
- -0.53
- Net Income Before Taxes
- -6.74
- Net Income
- -4.84
- Diluted Normalized EPS
- -4.59
- Period
- 2021
- Total Assets
- 114.49
- Total Liabilities
- 111.08
- Total Equity
- 3.4
- Tangible Book Valueper Share Common Eq
- -7.1
- Period
- 2021
- Cashfrom Operating Activities
- 7.43
- Cashfrom Investing Activities
- -1.44
- Cashfrom Financing Activities
- 6.2
- Net Changein Cash
- 12.19
- Period
- 2020
- Total Revenue
- 76.77
- Selling/ General/ Admin Expenses Total
- 24.63
- Depreciation/ Amortization
- 1.14
- Other Operating Expenses Total
- 29.07
- Total Operating Expense
- 69.8
- Operating Income
- 6.97
- Net Income Before Taxes
- 4.54
- Net Income
- 3.9
- Diluted Normalized EPS
- 3.69
- Period
- 2020
- Total Assets
- 93.6
- Total Liabilities
- 78.93
- Total Equity
- 14.67
- Tangible Book Valueper Share Common Eq
- 13.76
- Period
- 2020
- Cashfrom Operating Activities
- 4.99
- Cashfrom Investing Activities
- -4.03
- Cashfrom Financing Activities
- 0.85
- Net Changein Cash
- 1.81
- Period
- 2019
- Total Revenue
- 59.03
- Selling/ General/ Admin Expenses Total
- 20.92
- Depreciation/ Amortization
- 0.98
- Other Operating Expenses Total
- 19.47
- Total Operating Expense
- 53.67
- Operating Income
- 5.36
- Net Income Before Taxes
- 3.1
- Net Income
- 2.44
- Diluted Normalized EPS
- 1.33
- Period
- 2019
- Total Assets
- 92.29
- Total Liabilities
- 88.57
- Total Equity
- 3.73
- Tangible Book Valueper Share Common Eq
- -6.49
- Period
- 2019
- Cashfrom Operating Activities
- 12.29
- Cashfrom Investing Activities
- -2.9
- Cashfrom Financing Activities
- -11.55
- Net Changein Cash
- -2.17
- Period
- 2024-12-31
- Total Revenue
- 31.13
- Selling/ General/ Admin Expenses Total
- 13.11
- Depreciation/ Amortization
- 0.72
- Other Operating Expenses Total
- 13.62
- Total Operating Expense
- 33.04
- Operating Income
- -1.91
- Net Income Before Taxes
- -2.11
- Net Income
- -2.89
- Diluted Normalized EPS
- -2.4
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 30.41
- Selling/ General/ Admin Expenses Total
- 11.86
- Depreciation/ Amortization
- 1.98
- Other Operating Expenses Total
- 7.5
- Total Operating Expense
- 26.86
- Operating Income
- 3.55
- Net Income Before Taxes
- 3.48
- Net Income
- 3.42
- Diluted Normalized EPS
- 3.1
- Period
- 2024-09-30
- Total Assets
- 138.67
- Total Liabilities
- 102.62
- Total Equity
- 36.05
- Tangible Book Valueper Share Common Eq
- 8.04
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 0.95
- Cashfrom Investing Activities
- -11.2
- Cashfrom Financing Activities
- -5.06
- Net Changein Cash
- -15.31
- Period
- 2024-06-30
- Total Revenue
- 27.47
- Selling/ General/ Admin Expenses Total
- 9.76
- Depreciation/ Amortization
- 0.36
- Other Operating Expenses Total
- 10.91
- Total Operating Expense
- 27.03
- Operating Income
- 0.45
- Net Income Before Taxes
- 0.21
- Net Income
- 0.32
- Diluted Normalized EPS
- 0.33
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 32.91
- Selling/ General/ Admin Expenses Total
- 9.67
- Depreciation/ Amortization
- 0.35
- Other Operating Expenses Total
- 14.18
- Total Operating Expense
- 28.59
- Operating Income
- 4.31
- Net Income Before Taxes
- 0.79
- Net Income
- -0.04
- Diluted Normalized EPS
- -0.03
- Period
- 2024-03-31
- Total Assets
- 140.71
- Total Liabilities
- 108.54
- Total Equity
- 32.16
- Tangible Book Valueper Share Common Eq
- 8.2
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 2.03
- Cashfrom Investing Activities
- -1.26
- Cashfrom Financing Activities
- 17.64
- Net Changein Cash
- 18.42
- Period
- 2023-12-31
- Total Revenue
- 26.32
- Selling/ General/ Admin Expenses Total
- 8.86
- Depreciation/ Amortization
- 0.34
- Other Operating Expenses Total
- 10.48
- Total Operating Expense
- 25.65
- Operating Income
- 0.66
- Net Income Before Taxes
- 0.28
- Net Income
- -1
- Diluted Normalized EPS
- -0.95
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Kerala Ayurveda Technical
Moving Average
SMA
- 5 Day398.84
- 10 Day377.62
- 20 Day359.23
- 50 Day357.35
- 100 Day380.6
- 300 Day342.26
Kerala Ayurveda Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Dr. Agarwal's Eye Hospital
- 4328.6
- -69.3
- -1.58
- 7300
- 2800
- 2034.76
- Gpt Healthcare
- 155.2
- -0.85
- -0.54
- 206.5
- 126.15
- 1281.99
- Kerala Ayurveda
- 436.4
- 2.3
- 0.53
- 486.9
- 250
- 525.09
- Forbes And Company
- 373.5
- -7.6
- -1.99
- 787.95
- 264.35
- 481.76
- Aashka Hospitals
- 93.1
- -3.9
- -4.02
- 126.55
- 65.26
- 217.85
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Dr. Agarwal's Eye Hospital
- 43.19
- 12.79
- 29.64
- 10.83
- Gpt Healthcare
- 26.57
- 5.94
- 21.36
- 10.33
- Kerala Ayurveda
- -
- 15.84
- -2.12
- 0.07
- Forbes And Company
- 17.12
- 2.29
- -36.13
- -7.89
- Aashka Hospitals
- 96.14
- 2.36
- 2.55
- 5.12
Kerala Ayurveda Shareholding
Shareholding Pattern
*Promoter pledging: 7.83%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 14-Feb-25
- Quarterly Results
- 09-Dec-24
- Preferential issue of shares
- 14-Nov-24
- Quarterly Results
- 14-Aug-24
- Quarterly Results
- 29-May-24
- Audited Results
- 14-Feb-24
- Quarterly Results
- 14-Nov-23
- Quarterly Results
- 10-Aug-23
- Quarterly Results
- 30-May-23
- Audited Results
- 11-May-23
- Preferential issue of shares
- Meeting Date
- Announced on
- Purpose
- 03-Jan-25
- 11-Dec-24
- EGM
- 09-Jul-24
- 10-Jun-24
- POM
- 20-Dec-23
- 30-Nov-23
- EGM
- 27-Sept-23
- 11-Sept-23
- AGM
- 07-Jun-23
- 16-May-23
- EGM
- -
- 20-Aug-24
- AGM



